PRAA(PRAA)
PRAA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.22B | $1.22B |
| Low | $1.18B | $1.18B |
| High | $1.25B | $1.25B |
| EBITDA Avg | $155M | $154M |
| Low | $150M | $149M |
| High | $158M | $158M |
| EBIT Avg | $137M | $137M |
| Low | $133M | $133M |
| High | $141M | $141M |
| Net Income Avg | $97M | $109M |
| Low | $92M | $102M |
| High | $105M | $119M |
| EPS Avg | $2.52 | $2.83 |
| Low | $2.35 | $2.60 |
| High | $2.67 | $3.04 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $302M | $304M | $302M | $304M | $305M | $308M |
| Low | $291M | $293M | $291M | $293M | $294M | $297M |
| High | $310M | $313M | $311M | $312M | $314M | $317M |
| EBITDA Avg | $38M | $39M | $38M | $38M | $39M | $39M |
| Low | $37M | $37M | $37M | $37M | $37M | $38M |
| High | $39M | $40M | $39M | $40M | $40M | $40M |
| EBIT Avg | $34M | $34M | $34M | $34M | $34M | $35M |
| Low | $33M | $33M | $33M | $33M | $33M | $33M |
| High | $35M | $35M | $35M | $35M | $35M | $36M |
| Net Income Avg | $23M | $26M | $25M | $25M | $28M | $31M |
| Low | $22M | $25M | $24M | $24M | $26M | $30M |
| High | $24M | $27M | $26M | $26M | $29M | $32M |
| EPS Avg | $0.59 | $0.67 | $0.66 | $0.65 | $0.72 | $0.81 |
| Low | $0.56 | $0.64 | $0.62 | $0.62 | $0.69 | $0.77 |
| High | $0.61 | $0.70 | $0.68 | $0.67 | $0.75 | $0.84 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |